top of page

Aries Biotech wants to hear from you!

Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth?

Aries Biotech want to hear from you!

Your perspective holds immense value for us and we recognize the vital importance of gathering insights from individuals like you who possess a deep understanding of the intricacies of neuroscience and neurology. We cordially invite you to share your invaluable perspective by participating in a secure, private survey designed to capture your thoughts, experiences, and preferences regarding your role, interests, and the potential impact of #AI and #ML.

To participate in this survey, please follow this secure link.

Responses will not be shared with third parties and may be submitted anonymously. Your time and perspective are highly valued, and we thank you in advance for your contribution to our shared journey of scientific excellence.

Aries Biotech is a neurological disease and dementia biomarker consulting company that provides guidance, data interpretation, document review, and investor support. To learn more, visit Aries Biotech at

#neuroscience#neurology#neurologicaldisease#TBI#biomarker#diagnostics#IVD#vaccine#antibodytherapeutics#inhibitor#therapeutics#ml#ai #biotech #invest

6 views0 comments

Recent Posts

See All

Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believ

Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors Aries Biotechnologies is thrilled to introduce

Amyloid Beta Peptides as Biomarkers of Subconcussion Aries Biotech is pleased to share that a recent publication is now available within the Frontiers - Insights in Neurotrauma: 2021 E-Book. Increased

bottom of page